Status:
COMPLETED
Multiparametric Heart Failure Evaluation in Internal Cardioverter Defibrillators (ICD) Patients
Lead Sponsor:
University of Rome Tor Vergata
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
18-85 years
Brief Summary
The Boston Scientific Energen family is capable of measuring the respiratory rate trend (RRT) on a daily basis and transmission of data via the Remote Monitoring technology. This may result in early d...
Eligibility Criteria
Inclusion
- Patient eligible for 1-, 2- or 3-chamber ICD implantation according to current guidelines or patient already implanted within the past 45 days with a Energen device or successor
- Able to provide written informed consent
Exclusion
- Life expectancy \<12 months
- Anticipated non-compliance with the follow-up scheme
- Moderate to severe Chronic Obstructive Pulmonary Disease
- Primary pulmonary hypertension
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2014
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01501331
Start Date
December 1 2011
End Date
November 1 2014
Last Update
November 18 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Milan, Italy
2
Rome, Italy